This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
MRI and surveillance - Abstract
May 4, 2012
Active surveillance in prostate cancer: Patient selection and triggers for intervention - Abstract
May 4, 2012
High-risk prostate cancer: From definition to contemporary management - Abstract
May 4, 2012
Two decades' experience with a prospective biobank for urologic oncology: Research, clinical care, and the patients' view - Abstract
May 4, 2012
Open complete intrafascial nerve-sparing retropubic radical prostatectomy: Technique and initial experience - Abstract
May 4, 2012
Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men - Abstract
May 3, 2012
Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: Update on Southwest Oncology Group Study 9109 - Abstract
May 3, 2012
Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection - Abstract
May 3, 2012
Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden - Abstract
May 3, 2012
Docetaxel-based systemic chemotherapy in elderly Korean men with castration-resistant prostate cancer - Abstract
May 3, 2012
Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): A Trial of the Eastern Cooperative Oncology Group - Abstract
May 3, 2012
Dose reduction in LDR brachytherapy by implanted prostate gold fiducial markers - Abstract
May 3, 2012
Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: Assessment of clinical outcomes and predictive factors - Abstract
May 3, 2012
Environmental exposures and prostate cancer - Abstract
May 3, 2012
TGFβ1 SNPs and radio-induced toxicity in prostate cancer patients - Abstract
May 3, 2012
Very late prostate cancer local recurrence 23 years after radical prostatectomy - Abstract
May 2, 2012
Technical note: Suppression of artifacts arising from simultaneous cone-beam imaging and RF transponder tracking in prostate radiotherapy - Abstract
May 2, 2012
Prospective preference assessment of patients' willingness to participate in a randomized controlled trial of intensity-modulated radiotherapy versus proton therapy for localized prostate cancer - Abstract
May 2, 2012
Factors associated with diagnostic and treatment intervals for prostate cancer in Queensland, Australia: A large cohort study - Abstract
May 2, 2012
Concordance of tumor differentiation among brothers with prostate cancer - Abstract
May 2, 2012
Page 1310 of 1447
Start
Prev
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free